Story
Normal aging is not dementia: reactions slow down, but vocabulary and judgment often hold. A good part of dementia risk lies in changeable factors, so manage blood pressure, hearing, exercise, and social life first, not supplements.
regulates (3)
The chronic low-grade inflammation of an aging immune system is linked with cognitive decline and is thought to be one of its drivers. It is not the only cause, and it is intertwined with vascular and metabolic factors.
Bacopa takes about 12 weeks of daily use before any signal appears, because it is thought to work by slowly changing the structure of neurons. In animal studies, hippocampal neurons grew more dendritic branches. A single dose tested two hours later shows nothing. The positive results land most often on two things, learning a list of new words and how fast you process information, and the effects are small. For other measures such as working memory, some trials saw an improvement and some did not.
Part of the slowing of white matter in cognitive aging may come from local blood flow in the brain failing to keep up, but this chain is still an inference. When activity rises in part of the brain, neurons, glial cells and blood vessels work together to send more blood there; this is called neurovascular coupling. Some researchers propose that with age the small arteries respond to these signals more slowly, so local blood flow lags. The long, thin nerve fibers of the white matter are the most sensitive to a shortfall of blood. The chain has not been shown directly.
contrast (2)
The MIND diet was designed specifically to protect cognition, but saying it has been proven to prevent dementia goes too far. In a cohort study, people who stuck to it closely had slower cognitive decline, equivalent to being 7.5 years younger; but that is an observed association. The only randomised controlled trial followed 604 people for 3 years: cognition improved in both groups with no difference between them; and the control group also ate a healthy diet with mild calorie restriction.
Sharpening the mind and memory is ginseng's second-biggest selling point, but there is no convincing evidence that it improves cognition in healthy people. That is the conclusion of a Cochrane systematic review. Not because the trials all came out negative, but because no credible effect can be pooled from them. They used different outcome measures, durations and doses, and every usable trial was in healthy people.